Key Players Operating in Taiwan Hyaluronic Acid Market | Industry Leaders 2026

Key Players Operating in Taiwan Hyaluronic Acid Market

Taiwan Hyaluronic Acid Market is characterized by a dynamic blend of global pharmaceutical giants and regional biotech innovators, all competing for market share through advanced fermentation technology and localized cosmetic formulations. Major companies in the market include Galderma, Allergan (AbbVie), Shiseido Company, Limited, LG Chem, Hugel, Inc., SciVision Biotech Inc., Maxigen Biotech Inc. (MBI), Holy Stone Healthcare Co., Ltd., Gwo Xi Stem Cell Applied Technology, Freda Biopharm, Bloomage Biotechnology, K-Y Biotech, Seikagaku Corporation, and Anika Therapeutics.

Taiwan Hyaluronic Acid Market Overview

The Taiwan hyaluronic acid market is expected to increase significantly, driven by a rising expansion in medical aesthetics and aging-well sectors across East Asia. Hyaluronic acid is a naturally occurring biopolymer used in dermal fillers, osteoarthritis treatments, and high-end skincare to retain moisture and promote tissue repair. The market is motivated by the adoption of microbial fermentation processes and minimally invasive aesthetic procedures, which allows healthcare providers to meet the growing demand for anti-aging solutions. Furthermore, the combination of cross-linking technologies and bio-fermentation has become a standard for biotech firms in Kaohsiung and Taipei, as they seek to convert high-purity raw materials into premium medical-grade applications.

Competitive Landscape

The competitive landscape of the Taiwan hyaluronic acid market is characterized by a strong competition between global dermatology brands and local biotechnology specialists. Leading companies maintain an upward trajectory market share by offering diverse product portfolios that combine surgical adhesives, ophthalmic viscoelastic, and injectable fillers. Moreover, the market witness frequent collaborations between global pharmaceutical brands and local clinical distributors to provide tailored aesthetic training and implementation services that address specific beauty standards and regulatory requirements.

Below is a list of key players operating in the Taiwan Hyaluronic Acid Market:

1. Galderma

Galderma provides premium injectable aesthetics through its Restylane portfolio, helping Taiwanese clinics deliver science-driven facial rejuvenation.

2. Allergan (AbbVie Inc.)

Allergan offers the widely recognized Juvéderm collection of hyaluronic acid fillers, enabling Taiwanese practitioners to address structural facial contouring.

3. Shiseido Company, Limited

Shiseido is a major provider of hyaluronic acid-infused cosmetics and topical skincare, widely utilized by Taiwan’s extensive retail and personal care sector.

4. LG Chem Ltd.

LG Chem empowers medical professionals in Taiwan to utilize HICE cross-linking technology for high-stability dermal filler applications.

5. SciVision Biotech Inc.

A leading Taiwanese biotech company that develops medical-grade hyaluronic acid using its proprietary Cross-Linked Hyaluronic Acid Platform (CHAP).

6. Maxigen Biotech Inc. (MBI)

MBI specializes in biopolymer-based medical devices, offering hyaluronic acid products for orthopaedic, dental, and dermatology conditions.

7. Holy Stone Healthcare Co., Ltd.

Holy Stone is a biotechnology firm focused on the development of hyaluronic acid-based medical devices for tissue repair and specialized drug delivery.

8. Bloomage Biotechnology Corporation Limited

Bloomage is a global leader in raw material supply, providing various molecular weights of hyaluronic acid to Taiwan’s pharmaceutical and cosmetic manufacturers.

9. Seikagaku Corporation

Seikagaku specializes in glycoscience, providing critical joint health and ophthalmic surgical aids derived from high-purity hyaluronic acid.

10. Gwo Xi Stem Cell Applied Technology

An innovative biotech provider in Taiwan focusing on regenerative medicine and the integration of hyaluronic acid in advanced cell therapy.

Key Players Operating in Taiwan Hyaluronic Acid Market 2026 : FAQs